Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-06-018907
Filing Date
2006-03-20
Accepted
2006-03-20 18:40:07
Documents
1
Period of Report
2006-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3419
  Complete submission text file 0001209191-06-018907.txt   5245
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 3008 BURNING FREE LN CINCINNATI OH 45237
Business Address
LOVENBERG WALTER M PHD (Reporting) CIK: 0001213100 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 06699723